Neurocrine Biosciences, Inc. <NBIX.O>: Deutsche Bank raises target price to $190 from $170
NBIX•Related News
Amundi Physical Metals issues 60,000 new Amundi Physical Gold ETC securities in tranche 888
GLD•
Alnylam Pharmaceuticals Inc <ALNY.O>: Oppenheimer cuts target price to $350 from $500
ALNY•
Dominion tops second-quarter profit estimates as Virginia demand offsets rising expenses
D•
ING names Andrea Cesaroni to executive board as chief risk officer
ING•
Plus Therapeutics to trade on Nasdaq as Cerenome under CNSY ticker from Aug. 3
PSTV•